Body Weight and Risk of Oral Contraceptive Failure
Overview
Affiliations
Objective: To examine the hypothesis that higher body weight increases the risk of oral contraceptive (OC) failure.
Methods: We conducted a retrospective cohort analysis of data from 755 randomly selected female enrollees of Group Health Cooperative of Puget Sound who completed an in-person interview and dietary questionnaire between 1990 and 1994 as control subjects for a case-control study of ovarian cysts. Among the 618 women who were OC ever-users, we used Cox proportional hazards regression models to estimate the relative risk (RR) of pregnancy while using OCs associated with body weight quartile.
Results: During 2822 person-years of OC use, 106 confirmed pregnancies occurred (3.8 per 100 person-years of exposure). After controlling for parity, women in the highest body weight quartile (70.5 kg or more) had a significantly increased risk of OC failure (RR 1.6, 95% confidence interval [CI] 1.1, 2.4) compared with women of lower weight. Higher elevations of risk associated with the highest weight quartile were seen among very low-dose OC users (RR 4.5, 95% CI 1.4, 14.4) and low-dose OC users (RR 2.6, 95% CI 1.2, 5.9), controlling for parity, race, religion, and menstrual cycle regularity.
Conclusion: Our findings suggest that body habitus may affect metabolism sufficiently to compromise contraceptive effectiveness. Consideration of a woman's weight may be an important element of OC prescription.
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.
Nguyen A, Curtis K, Tepper N, Kortsmit K, Brittain A, Snyder E MMWR Recomm Rep. 2024; 73(4):1-126.
PMID: 39106314 PMC: 11315372. DOI: 10.15585/mmwr.rr7304a1.
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
Luo D, Westhoff C, Edelman A, Natavio M, Stanczyk F, Jusko W Contraception. 2019; 99(4):256-263.
PMID: 30684471 PMC: 6441376. DOI: 10.1016/j.contraception.2018.12.009.
The emerging role of obesity in short-acting hormonal contraceptive effectiveness.
Edelman A, Trussell J, Aiken A, Portman D, Chiodo 3rd J, Garner E Contraception. 2017; 97(5):371-377.
PMID: 29269251 PMC: 6049839. DOI: 10.1016/j.contraception.2017.12.012.
Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y PLoS One. 2017; 12(7):e0182045.
PMID: 28732067 PMC: 5521832. DOI: 10.1371/journal.pone.0182045.
Dragoman M, Simmons K, Paulen M, Curtis K Contraception. 2016; 95(2):117-129.
PMID: 27823942 PMC: 11283816. DOI: 10.1016/j.contraception.2016.10.010.